Skip to search formSkip to main contentSkip to account menu

Multifunctional/Multitargeted Anticancer Agent OMN54

Known as: MFMT OMN54, OMN54 
An orally available, multivalent herbal formulation containing a novel mixture of whole extracts from three commonly used Chinese medicinal herbs… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Aneustat (OMN54) is a multivalent, botanical anticancer candidate therapeutic. A recent Phase‐I clinical trial has indicated that… 
2018
2018
Background:Docetaxel used for first-line treatment of advanced prostate cancer (PCa) is only marginally effective. We previously… 
2015
2015
Purpose: With the increasing interest in natural products as therapeutics, we performed a Phase I open label study of OMN54 in… 
Review
2010
Review
2010
Objective To gain insight into the use of quality systems to improve urinary incontinence (UI) care in older adults receiving… 
2009
2009
Chinese medicine often targets more than one system and as such comprises several compounds, often in non-purified form, with… 
2007
2007
C67 Aneustat (OMN54), a natural product derivative, has anti-tumor, anti-inflammatory and immuno-modulatory activity as a single…